Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection
Abstract Background Dalbavancin is a lipoglycopeptide antibiotic approved for treatment of skin and soft tissue infections, administered as a single or two-dose treatment. The extended half-life, good penetration into bone and synovial fluid, and bactericidal activity against gram-positive bacteria,...
Na minha lista:
| Principais autores: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2023-10-01
|
| 叢編: | BMC Infectious Diseases |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1186/s12879-023-08709-8 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|